Related Experiment Video

Updated: Jul 5, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses

W Mendling1, U Koldovsky

  • 1Department of Gynecology and Obstetrics Wuppental St. Antonius Hospital Düsseldorf Heinrich Heine Uiversität Düsseldorf Germany.

Infectious Diseases in Obstetrics and Gynecology
|January 1, 1996
PubMed

Insights

Recurrent vaginal candidosis may stem from diminished peripheral T lymphocytes. Immunologic treatment with thymopentin can help restore T-helper cells and reduce candidosis relapses.

Area of Science:

  • Immunology
  • Mycology
  • Infectious Diseases

Background:

  • Chronic recurrent vaginal candidosis presents therapeutic challenges.
  • Investigating immunologic factors is crucial for understanding treatment failures.

Purpose of the Study:

  • To identify immunologic factors contributing to chronic recurrent vaginal candidosis.
  • To evaluate the efficacy of immunologic treatment for recurrent cases.

Main Methods:

  • Studied T lymphocytes and subpopulations in women with acute and chronic vaginal candidosis (Candida albicans and C. glabrata).
  • Conducted in vitro T lymphocyte proliferation tests.
  • Administered thymopentin to patients with chronic recurrent candidosis and monitored clinical outcomes.

Main Results:

  • Women with C. albicans vulvovaginitis had reduced peripheral T lymphocytes compared to healthy controls.
  • Non-specific killer (NK) cells were lower in acute C. albicans infections.
  • Thymopentin treatment led to recovery in patients with initially low T-helper cells.

Conclusions:

  • Diminished peripheral T lymphocytes may be a factor in chronic recurrent C. albicans vaginitis.
  • Immunologic treatment, specifically with thymopentin, can decrease relapse rates in these patients.
Abstract

More Related Videos

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis07:57

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis

Published on: December 8, 2011

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.